Items Tagged ‘Crohn’s disease’
November 19, 2018
Regenerative medicine is the future for Dr. Amy Lightner
Volunteering for a reading program at a children’s hospital led to a career change for Amy Lightner, M.D. As a Stanford University undergraduate, she met a cardiac surgeon who turned her interest to medicine. “I got to see how medicine and surgical intervention could change a child’s life forever,” says Dr. Lightner. “The research, in […]
Tags: Amy Lightner, Center for Regenerative Medicine, Crohn's disease, IBD, inflammatory bowel disease, medical research, regenerative medicine, stem cells, ulcerative colitis
December 9, 2013
Mayo Clinic Debuts Two New Blogs Focused on Celiac Disease and Inflammatory Bowel Disease (IBD)
We are excited to unveil Mayo Clinic’s newest blogs, which focus on celiac disease and inflammatory bowel disease (IBD, which includes Crohn’s disease and ulcerative colitis). The blogs feature commentary from Mayo Clinic experts about most recent news and advances within each disease, specifically: Study findings News alerts Clinical trials Upcoming events Disease management […]
Tags: celiac disease, Crohn's disease, gastroenterology, IBD, inflammatory bowel disease, ulcerative colitis
August 30, 2013
Vedolizumab Effective for Treatment of Ulcerative Colitis & Crohn’s Disease – IBD in the News
Sunanda Kane, M.D., a gastroenterologist at Mayo Clinic specializing in the care and evaluation of patients with IBD, discusses two studies recently published in “The New England Journal of Medicine” (ulcerative colitis study | Crohn’s disease study) that found patients with ulcerative colitis or Crohn’s disease benefited from treatment with vedolizumab compared with placebo. Dr. […]
Tags: Crohn's disease, gastroenterology, IBD, inflammatory bowel disease, ulcerative colitis
June 26, 2013
Changes to Medications Used to Treat Ulcerative Colitis – IBD in the News
Sunanda Kane, M.D., a gastroenterologist at Mayo Clinic specializing in the care and evaluation of patients with IBD, discusses recent changes to drugs used to treat ulcerative colitis and how these changes could impact patients who take these drugs. Medications discussed include: Asacol, Delzicol, Colazal, Giazo, Apriso For more information on IBD, visit: mayoclinic.org/ibd
Tags: Crohn's disease, gastroenterology, IBD, inflammatory bowel disease, ulcerative colitis
June 19, 2013
IBD & Increased Risk of Melanoma – IBD in the News
Siddharth Singh, M.B.B.S., a gastroenterologist at Mayo Clinic specializing in the care and evaluation of patients with IBD, discusses the patient takeaways from a Mayo Clinic study presented at the Digestive Disease Week 2013 conference that found patients with IBD are at higher risk for melanoma, a type of skin cancer. Among the most important […]
Tags: Crohn's disease, gastroenterology, IBD, inflammatory bowel disease, ulcerative colitis
April 30, 2013
Edward Loftus Jr., M.D., a gastroenterologist at Mayo Clinic specializing in the care and evaluation of patients with IBD, discusses the implications of recent article published in Alimentary Pharmacology & Therapeutics that found a group of patients with IBS to have higher CDAI scores than patients with Crohn’s disease. Specifically, Dr. Loftus mentions: – Because […]
Tags: Crohn's disease, Edward Loftus, gastroenterology, IBD, inflammatory bowel disease, ulcerative colitis